Confirmed detection of N-pyrrolidino protonitazene and protonitazene in Queensland

Published on October 3, 2025
There has been a recent case of N-pyrrolidino protonitazene (also known as protonitazepyne) and protonitazene detected in toxicology and tablet samples, in South-East Queensland. N-pyrrolidino protonitazene and protonitazene are very strong synthetic opioids that work like heroin or fentanyl and can produce life-threatening toxicity in small amounts. The appearance of the sample is a pale
Continue reading on website
Other news

Harm reduction practises for users of psychedelic drugs: a scoping review

October 3, 2025
Psychedelic use in naturalistic settings in Australia is increasing. Although the risks and harms of psychedelics from a physical perspective are low, psychedelic drugs carry a unique psychological risk profile which is increased in uncontrolled settings. Harm reduction support services align with the Australian Government’s Federal Drug strategy, which includes harm reduction as the third pillar

Methylmeth-aqualone and flurofentanyl found in ‘opioid’ capsule

October 3, 2025
A capsule filled with an off-white powder expected to contain an unknown opioid was found to contain methylmethqualone and a fluorofentanyl. CanTEST has detected MMQ by itself previously (a Yellow Community Notice was issued in Nov 2024). Effects Methylmethqualone (MMQ) is an analogue of the more common methaqualone (MQ). It’s a quinazolone sedative hypnotic –